Cargando…

MS-Therapie im Alter - Was gilt es zu bedenken?

Detalles Bibliográficos
Autores principales: Pawlitzki, Marc, Meuth, Sven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700109/
http://dx.doi.org/10.1007/s15202-020-2900-6
_version_ 1783616202130587648
author Pawlitzki, Marc
Meuth, Sven G.
author_facet Pawlitzki, Marc
Meuth, Sven G.
author_sort Pawlitzki, Marc
collection PubMed
description
format Online
Article
Text
id pubmed-7700109
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-77001092020-12-01 MS-Therapie im Alter - Was gilt es zu bedenken? Pawlitzki, Marc Meuth, Sven G. DNP Fortbildung Springer Medizin 2020-12-03 2020 /pmc/articles/PMC7700109/ http://dx.doi.org/10.1007/s15202-020-2900-6 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Fortbildung
Pawlitzki, Marc
Meuth, Sven G.
MS-Therapie im Alter - Was gilt es zu bedenken?
title MS-Therapie im Alter - Was gilt es zu bedenken?
title_full MS-Therapie im Alter - Was gilt es zu bedenken?
title_fullStr MS-Therapie im Alter - Was gilt es zu bedenken?
title_full_unstemmed MS-Therapie im Alter - Was gilt es zu bedenken?
title_short MS-Therapie im Alter - Was gilt es zu bedenken?
title_sort ms-therapie im alter - was gilt es zu bedenken?
topic Fortbildung
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700109/
http://dx.doi.org/10.1007/s15202-020-2900-6
work_keys_str_mv AT pawlitzkimarc mstherapieimalterwasgilteszubedenken
AT meuthsveng mstherapieimalterwasgilteszubedenken